Sign up
Pharma Capital

ITUS Corporation CEO Robert Berman presents at Biotech Capital Conference

ITUS Corporation CEO Robert Berman presents at Biotech Capital Conference 

 
Sarah_55b0a64c2a6b3.jpg

View full ITUS profile

ITUS Corp Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.